PLPP3 and congenital bilateral aplasia of vas deferens from CFTR mutation: Recent findings also indicate that epigenetically-driven processes lower the expression of phospholipid phosphatase 3 (PLPP3) and increased LysoPA signaling and inflammation in the aortic valve during CAVD.